Dr Juan Antonio Rodriguez Jr, MDW in Hatillo, PR - Medicare Orthopedic Surgery

Dr Juan Antonio Rodriguez Jr, MDW is a medicare enrolled "Orthopaedic Surgery" physician in Hatillo, Puerto Rico. He went to University Of Puerto Rico School Of Medicine and graduated in 1989 and has 35 years of diverse experience with area of expertise as Orthopedic Surgery. His current practice location is Carret. #2 Km 86.7, Bo. Pueblo, Hatillo, Puerto Rico. You can reach out to his office (for appointments etc.) via phone at (787) 898-3517.

Dr Juan Antonio Rodriguez Jr is licensed to practice in Puerto Rico (license number 11193) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1215912613.

Contact Information

	Dr Juan Antonio Rodriguez Jr, MDW
	Carret. #2 Km 86.7, Bo. Pueblo, Hatillo, PR 00659
	(787) 898-3517
	(787) 898-3517

Physician's Profile

Full Name	Dr Juan Antonio Rodriguez Jr
Gender	Male
Speciality	Orthopedic Surgery
Experience	35 Years
Location	Carret. #2 Km 86.7, Hatillo, Puerto Rico
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Juan Antonio Rodriguez Jr attended and graduated from University Of Puerto Rico School Of Medicine in 1989

NPI Data:

NPI Number: 1215912613
Provider Enumeration Date: 12/08/2005
Last Update Date: 06/03/2011

Medicare PECOS Information:

PECOS PAC ID: 6608948401
Enrollment ID: I20080711000058

Medical Identifiers

Medical identifiers for Dr Juan Antonio Rodriguez Jr such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1215912613	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207X00000X	Orthopaedic Surgery	11193 (Puerto Rico)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Juan Antonio Rodriguez Jr is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Juan Antonio Rodriguez Jr, MDW Po Box 142487, Arecibo, PR 00614-2487 Ph: (787) 898-3517	Dr Juan Antonio Rodriguez Jr, MDW Carret. #2 Km 86.7, Bo. Pueblo, Hatillo, PR 00659 Ph: (787) 898-3517

News Archive

Children in foster care still face quality challenges in antipsychotic medication use

Significant quality challenges persist in antipsychotic medication use for children in foster care and other Medicaid-insured children, according to a new Rutgers University-New Brunswick study published in Health Affairs.

UCLA study characterizes brain differences between people with genetic risk for schizophrenia, autism

A UCLA study characterizes, for the first time, brain differences between people with a specific genetic risk for schizophrenia and those at risk for autism, and the findings could help explain the biological underpinnings of these neuropsychiatric disorders.

Prenatal pesticide exposure increases susceptibility to ADHD in children

Exposure to organophosphate (OP) pesticides before birth can increase susceptibility to attention disorders such as attention deficit/hyperactivity disorder (ADHD), according to new research published in the journal Environmental Health Perspectives (EHP). The new study is part of a growing body of research indicating that exposure to OP pesticides can adversely affect brain development.

UCB sponsoring several presentations on Cimzia for Crohn's disease at DDW 2015

UCB, a global biopharmaceutical company focusing on immunology and neurology treatment and research, is sponsoring several data presentations on Cimzia (certolizumab pegol) at Digestive Disease Week 2015, taking place in Washington, DC from May 16-19.

Dr. Reddy's launches generic version of PLAVIX

Dr. Reddy's Laboratories announced today that it has launched CLOPIDOGREL TABLETS, USP 75 mg & 300 mg, a bioequivalent generic version of PLAVIX, in the U.S. market on May 18, 2012.

Dr Juan Antonio Rodriguez Jr, MDW - Medicare Orthopedic Surgery in Hatillo, PR